Howorth Air Technology is collaborating with Texas-based G-CON Manufacturing to provide a flexible solution for pharmaceutical containment that meets standards for safety and cleanliness for GMP therapeutics manufacturing.
Howorth will combine its expertise in engineering clean air and isolator technologies with G-CON’s self-contained mobile cleanroom PODs, allowing customers to meet safety and regulatory needs without risking process productivity.
Howorth’s clean air engineering allows for a controlled flow of air, enabling contaminates to be carried away for optimal containment. G-CON’s PODs are scalable and can be repurposed and used in multiproduct or individual patient scenarios.
“G-CON offers a market leading technology, product and service, and fundamental synergies with which Howorth is proud to be allied,” said Graham Hind, CEO of Howorth Air Technology Inc, Howorth’s US subsidiary.
“The flexibility of both companies will provide the pharmaceutical and biopharmaceutical markets with the best single source solutions, and absolute quality and service.”
Maik Jornitz, CEO of G-CON Manufacturing, added: “We are very excited to partner with Howorth Air Technology, a leading containment and aseptic technologies provider. The combination of G-CON’s cleanroom PODS and Howorth’s containment options meets current biopharmaceutical industry demands, especially with increasing potency of therapeutic drug products of individual patient therapies.”
G-CON has made Howorth Air Technology its preferred service provider with regard to containment products, aseptic solutions, and hospital solutions.
